691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

A.M. Schram; G. Lopes; A.B. El-Khoueiry; E. Fontana; T.B. Karasic; S. Kummar; P. Lorusso; V. Gregorc; M. Millward; S. Ponce Aix; D.L. Richardson; D. Roda Perez; A.I. Spira; D.S. Tan; J.A. Thompson; D. Uprety; M. Fellous; Y.G. Qin; E.E. Dumbrava

doi:10.1016/j.annonc.2024.08.2162

Back

691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

Journal article

Peer reviewed

691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

A.M. Schram, G. Lopes, A.B. El-Khoueiry, E. Fontana, T.B. Karasic, S. Kummar, P. Lorusso, V. Gregorc, M. Millward, S. Ponce Aix, …

Annals of oncology, Vol.35, pp.S535-S536

2024-09

DOI: https://doi.org/10.1016/j.annonc.2024.08.2162

Appears in Miller School of Medicine - Latest Publications

Metrics

4 Record Views

See more details

Details

Title: 691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation
Creators: A.M. Schram - Memorial Sloan Kettering Cancer Center
G. Lopes - Sylvester Comprehensive Cancer Center
A.B. El-Khoueiry - USC Norris Comprehensive Cancer Center
E. Fontana - Sarah Cannon Research Institute
T.B. Karasic - University of Pennsylvania
S. Kummar - OHSU Knight Cancer Institute
P. Lorusso - Yale Cancer Center
V. Gregorc - Oncology Dept., Fondazione del Piemonte per l’Oncologia (IRCCS), Turin, Italy
M. Millward - Linear Clinical Research
S. Ponce Aix - Institut Gustave Roussy
D.L. Richardson - University of Oklahoma
D. Roda Perez - Hospital Clínico Universitario de Valencia
A.I. Spira - Virginia Cancer Specialists
D.S. Tan - Department of Haematology-Oncology, National University of Singapore (NUS) Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine and National University Cancer Institute, National University Hospital, Singapore
J.A. Thompson - Fred Hutch Cancer Center
D. Uprety - Medical Oncology Department, Karmanos Cancer Institute, Detroit, MI, USA
M. Fellous - Medical Affairs, PMV Pharmaceuticals Inc, Princeton, NJ, USA
Y.G. Qin - Medical Affairs, PMV Pharmaceuticals Inc, Princeton, NJ, USA
E.E. Dumbrava - The University of Texas MD Anderson Cancer Center
Publication Details: Annals of oncology, Vol.35, pp.S535-S536
Publisher: Elsevier Ltd
Grant note: PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc.
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032366237402976